C
AURA icon

Covestor’s Aura Biosciences AURA Stock Holding History

Covestor’s Portfolio AURA Stock Details AURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$0 Sell
10
-9
-47% -$52 ﹤0.01% 2251
2025
Q4 		$0 Buy
+19
New +$113 ﹤0.01% 2256
2025
Q3 		– Sell
-26
Closed – – 2276
2025
Q2 		$0 Buy
+26
New +$152 ﹤0.01% 2197

Other funds holding AURA

MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MVM
Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Covestor's AURA Position: Q1 2026 in Review

Covestor reduced its Aura Biosciences (AURA) stake by 47% in Q1 2026, selling an estimated $52 and leaving 10 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #2251.

Covestor first reported a position in AURA in Q2 2025 and has held it in 3 quarters since. 126 funds tracked by Wall St. Rank hold AURA as of Q1 2026.

  • Covestor held 10 shares of Aura Biosciences worth $0 as of Q1 2026.
  • Covestor sold 9 Aura Biosciences shares in Q1 2026, an estimated $52.
  • Aura Biosciences made up ﹤0.01% of Covestor's portfolio in Q1 2026, its #2251 holding.
  • Covestor first reported a position in Aura Biosciences in Q2 2025 and has held it in 3 quarters since.
  • 126 funds tracked by Wall St. Rank held Aura Biosciences as of Q1 2026.

Based on Covestor's 13F filing for Q1 2026, filed 5 May 2026.